Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

2care4 generics aps - methadonum hýdróklóríð - tafla - 10 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

2care4 generics aps - methadonum hýdróklóríð - tafla - 20 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

2care4 generics aps - methadonum hýdróklóríð - tafla - 5 mg

Evrópusambandið - íslenska - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - eitilfrumukrabbamein, mantle-cell - Æxlishemjandi lyf - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Evrópusambandið - íslenska - EMA (European Medicines Agency)

3m health care limited - rivastigmin - alzheimer sjúkdómur - psychoanaleptics, , anticholinesterases - einkennum meðferð vægt til nokkuð alvarlega alzheimer heilabilun.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - mixtúra, dreifa - 1 mg/ml

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 5 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 180 mg